公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | Management of hepatitis C virus infection in the Asia-Pacific region: an update | Lim S.G.; Aghemo A.; PEI-JER CHEN ; Dan Y.Y.; Gane E.; Gani R.; Gish R.G.; Guan R.; Jia J.D.; Lim K.; Piratvisuth T.; Shah S.; Shiffman M.L.; Tacke F.; Tan S.S.; Tanwandee T.; Win K.M.; Yurdaydin C. | The Lancet Gastroenterology and Hepatology | 49 | 43 | |
2019 | Peginterferon alfa-2a (40 kD) stopping rules in chronic hepatitis B: A systematic review and meta-analysis of individual participant data | Pavlovic V.; Yang L.; Chan H.L.-Y.; Hou J.; Janssen H.L.; JIA-HORNG KAO ; Lampertico P.; Peng C.-Y.; Piratvisuth T.; Thompson A.J.; Wedemeyer H.; Wei L.; Wat C. | Antiviral Therapy | 11 | 7 | |
2015 | Randomized, controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon in patients with chronic hepatitis B infection | Colvin R.A.; Tanwandee T.; Piratvisuth T.; Thongsawat S.; Hui A.J.; Zhang H.; Ren H.; PEI-JER CHEN ; Chuang W.-L.; Sobhonslidsuk A.; Li R.; Qi Y.; Praestgaard J.; Han Y.; Xu J.; Stein D.S.; Chien R.-N.; Flisiak R.; Jablkowski M.; Liaw Y.-F.; Sung J.J.-Y. | Journal of Gastroenterology and Hepatology (Australia) | 6 | 6 | |
2015 | Reimbursement policies in the Asia-Pacific for chronic hepatitis B | Lim S.G.; Amarapurkar D.N.; Chan H.L.-Y.; Crawford D.H.; Gane E.J.; Han K.-H.; Ahn S.H.; Jafri W.; Jia J.; JIA-HORNG KAO ; Lesmana L.A.; Lesmana C.R.A.; Mohamed R.; Phiet P.H.; Piratvisuth T.; Sarin S.K.; Sollarno J.D.; Eguchi Y.; Mahtab M.-A.; Lee K.H. | Hepatology International | 21 | 19 | |
2011 | A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt | Sievert W.; Altraif I.; Razavi H.A.; Abdo A.; Ahmed E.A.; Alomair A.; Amarapurkar D.; CHIEN-HUNG CHEN ; Dou X.; El Khayat H.; elShazly M.; Esmat G.; Guan R.; Han K.-H.; Koike K.; Largen A.; Mccaughan G.; Mogawer S.; Monis A.; Nawaz A.; Piratvisuth T.; Sanai F.M.; Sharara A.I.; Sibbel S.; Sood A.; Suh D.J.; Wallace C.; Young K.; Negro F. | Liver International | 444 | 416 | |
2010 | Treatment of chronic hepatitis B in Asia-Pacific countries: Is the Asia-Pacific consensus statement being followed? | Sung J.J.Y.; Amarapurkar D.; Chan H.L.Y.; Cheng J.; JIA-HORNG KAO ; Han K.-H.; Piratvisuth T. | Antiviral Therapy | 9 | 9 |